# PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection

> **NCT03239899** · PHASE1 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 13 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Pembrolizumab

## Key facts

- **NCT ID:** NCT03239899
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-09
- **Primary completion:** 2023-02-13
- **Final completion:** 2023-02-13
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03239899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03239899, "PD-1 Inhibition to Determine CNS Reservoir of HIV-Infection". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03239899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*